We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Guangdong Fapon Biotech Co., Ltd.

Download Mobile App




Automated Sample-to-Result PCR Test Enables Rapid Genotyping for Antiplatelet Therapy

By LabMedica International staff writers
Posted on 27 Mar 2023

The CYP2C19 enzyme plays a critical role in metabolizing approximately 10% of current clinically used medications, including anti-platelet drugs, proton pump inhibitors, and antidepressants. More...

Genetic variability of CYP2C19 can have an impact on the clinical efficacy and safety of these medications. High-risk mutations in approximately 3 in 10 individuals can impair the function of drugs affected by this enzyme. Determining whether a patient is likely to respond favorably to the prescribed medication can enhance healthcare for individuals. The rapid genotyping of CYP2C19 helps physicians select the most effective medications for their patients.

The Genomadix Cube CYP2C19 System (Cube CYP2C19 test), an automated sample-to-result PCR test from Genomadix (Ottawa, Canada), can be used by clinicians to determine the therapeutic strategy for drugs metabolized by the CYP450 2C19 genetic pathway. Genomadix Cube CYP2C19 System identifies the CYP2C19 2, 3, and 17 alleles, if present, directly from buccal swab in approximately one hour.

The Genomadix Cube is a molecular diagnostic instrument that employs polymerase chain reaction (PCR) technology to test for genetic, infectious disease, and environmental targets using a sample-to-result platform. Its portable size, user-friendly design, and ability to deliver on-demand results enable users to generate time-critical results. The Genomadix Cube CYP2C19 System is commercially distributed in Europe, as well as all countries recognizing the CE Mark (CE-IVD), and has now been granted 510(k) clearance by the US Food and Drug Administration (FDA).

"The Genomadix Cube CYP2C19 System empowers physicians to make informed decisions on appropriate drug selection for a number of precision medicine indications such as antiplatelet therapy in both stroke and cardiology patients," said Steve Edgett, Genomadix's Chief Executive Officer."

Related Links:
Genomadix


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Measuring six variants from one sample may improve research efficiency and support clinical trials of amyloid biology in Alzheimer’s disease and related conditions (Image Credit: Adobe Stock)

Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research

Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.